SLU7 and breast cancer: In order to systematically evaluate the role of the complete spliceosome during breast cancer development and progression, we compared RNA expression levels of every single splicing factor (244 in total, derived from Hegele et al. 3) between normal mammary gland tissue and matched primary breast tumor (Fig. 1A–D) and between primary breast tumor and metastatic tissue (Fig. 1E–H) using matched patient RNA sequencing data from 114 and 7 patients respectively, obtained from The Cancer Genome Atlas (TCGA).